Kentaro Suzuki insider trades

Open-market stock purchases and sales by Kentaro Suzuki, Chief Marketing Officer at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Sep 16, 2024.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +74%.

Recent trades

DateStockTradeValue
Mar 2, 2026NAUT Nautilus Biotechnology, IncBought (not open market)—
Nov 6, 2025NAUT Nautilus Biotechnology, IncBought$6K

Companies traded

  • NAUT Nautilus Biotechnology, Inc: 1 buy, last Mar 2, 2026

Get free alerts when Kentaro Suzuki files a new trade →